Immunogenicity and Safety of Pentaxim in South African Infants - Related Studies

Immunogenicity and Safety of Pentaxim in South African Infants

This study is ongoing, but not recruiting participants.

Study NCT00254969. Last updated on March 31, 2008. Information provided by Sanofi-Aventis

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Diphtheria
		Tetanus
		Haemophilus Infections
		Pertussis
		Poliomyelitis

2	Additional conditions recognized in this trial
		Infection
		Whooping Cough

3	More general conditions related to this trial
		Actinomycetales Infections
		Bacterial Infections
		Bordetella Infections
		Central Nervous System Diseases
		Central Nervous System Infections
		Central Nervous System Viral Diseases
		Clostridium Infections
		Corynebacterium Infections
		Enterovirus Infections
		Gram-Negative Bacterial Infections
		Gram-Positive Bacterial Infections
		Motor Neuron Disease
		Myelitis
		Nervous System Diseases
		Neuromuscular Diseases
		Pasteurellaceae Infections
		Picornaviridae Infections
		Respiratory Tract Diseases
		Respiratory Tract Infections
		RNA Virus Infections
		Spinal Cord Diseases
		Virus Diseases

4	Sponsors listed in this trial
		Sanofi-Aventis